Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Chemosphere ; 339: 139727, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37541441

RESUMEN

In this study, the effects of 100 nm boron nanoparticles (B-NPs) on the primary antioxidant status of Nile tilapia were researched via analysis of enzyme activities and related gene expressions. This is a new study which focuses on the relationship between B-NPs and oxidative stress that contribute to the literature in terms of its scope. Fish (n = 15) for each group were exposed to three different concentrations as 5, 25 (n2) and 125 (n3) mg/L during 96 h to see the response of the primary antioxidant system. According to the results, SOD expressions differed in all treatment groups compared to the control group (P < 0.05). CAT expressions were different in 5 and 125 mg/L groups compared to control and 25 mg/L groups (P < 0.05). GPX expressions were only different in 125 mg/L group (P < 0.05). The changes in enzyme activities of SOD and CAT were significantly different in 25 mg/L groups. GPX enzyme activities were not significant (P > 0.05). TBARS concentrations in 25 mg/L group were significantly different from those in the control and 125 mg/L groups (P < 0.05).


Asunto(s)
Cíclidos , Nanopartículas , Animales , Antioxidantes/metabolismo , Cíclidos/genética , Cíclidos/metabolismo , Boro/toxicidad , Boro/metabolismo , Estrés Oxidativo , Nanopartículas/toxicidad , Superóxido Dismutasa/metabolismo , Alimentación Animal/análisis , Dieta , Suplementos Dietéticos
2.
Dev Comp Immunol ; 138: 104553, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36122732

RESUMEN

The intensification and diversification of production systems have increased the incidence of diseases, which are usually treated with antibiotics. However, its use should be restricted due to the increasing prevalence of antibiotic-resistant bacteria. Probiotics represent therefore an alternative environmentally friendly strategy for improving growth and disease resistance in aquaculture. Considering that host-derived probiotics may offer greater advantages than those from other environments in terms of safety and efficacy, two potential host-associated probiotic strains (Bacillus mojavensis B191 and Bacillus subtilis MRS11) were used in the present study, which were previously isolated from intestinal mucus of Nile tilapia (Oreochromis niloticus). This study was conducted to assess the effects of dietary administration of two Bacillus strains on growth performance, intestinal morphology, immunity, and disease resistance of Nile tilapia. A total of 375 fish were randomly divided into five groups in triplicate. Nile tilapia were fed a basal diet (control group) or a basal diet supplemented with Bacillus mojavensis B191 (BM) or Bacillus subtilis MRS11 (BS) spores at different concentrations of 1 × 106 (BM6 and BS6, respectively) and 1 × 108 (BM8 and BS8, respectively) CFU/g of feed for 60 days. Moreover, the survival rate of tilapia upon challenge with Streptococcus iniae was determined following the feeding trial. After the feeding trial, the growth performances were significantly improved in all probiotic-fed groups, with the BS8 group being the highest. Light and electron microscopy observations revealed elevated goblet cells, intestinal villus length (except BM8), microvilli length, microvilli density, and perimeter ratio increase in the intestine of all probiotic-fed groups compared with the control group. Regarding the expression analysis, HSP70 gene was only up-regulated in the BM8 group and a general trend of up-regulation of some immune-related cytokines (TGF-ß, IL-10, TNF-α and IL-1ß) was observed in all probiotic-fed groups. Likewise, the best protection against Streptococcus iniae was observed in the BS8 group, followed by BS6, BM6 and BM8 groups. Altogether, dietary probiotic supplementation with BS8 and BM6 may improve growth performance, intestinal morphology, immunity, and disease resistance in Nile tilapia.


Asunto(s)
Bacillus , Cíclidos , Enfermedades de los Peces , Probióticos , Alimentación Animal/análisis , Animales , Antibacterianos/farmacología , Bacillus subtilis , Dieta , Suplementos Dietéticos , Resistencia a la Enfermedad , Interleucina-10 , Intestinos , Streptococcus iniae/fisiología , Factor de Crecimiento Transformador beta , Factor de Necrosis Tumoral alfa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA